GLP-1 Agonists

DBCAT002693Therapeutic category

Glucagon-like peptide-1 receptor agonists also known as GLP-1 receptor agonists or incretin mimetics are agonists of the GLP-1 receptor. This class of drugs is used for the treatment of type 2 diabetes. A DrugBank category of 10 drugs. 8 of them are approved.

Part of: Blood Glucose Lowering Agents
Also known as: GLP 1 Analogs · GLP-1 analogues · GLP-1 Receptor Agonist · GLP-1-Agonists · GLP1 Analogs
Drugs: Albiglutide
Beinaglutide
Dulaglutide
Exenatide
Liraglutide
Lixisenatide
Orforglipron
Semaglutide
Taspoglutide
Tirzepatide

What you can answer from here — as of July 14, 2021

10DrugsEach linked to its full drug card

Listed above

2Drug targetsEvery drug–target pair in the class, with bond type

707Marketed productsAcross the regions we cover, with dosage forms and routes

4Routes of administrationHow the drugs in this class are given

Which targets do GLP-1 Agonists share, and which companies have late-stage candidates in this class?

Answer this in Biopharma OS Sign in to your account

Create a free account or log in to explore the full data card.

Create Account